On the Interplay of Telomeres, Nevi and the Risk of Melanoma

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Bodelon, Clara ^a   Pfeiffer, Ruth M ^a   Bollati, Valentina ^b,c   Debbache, Julien ^a,d   Calista, Donato ^e   Ghiorzo, Paola ^f,g   Fargnoli, Maria Concetta ^h   Bianchi Scarra, Giovanna ^f,g   Peris, Ketty ^h   Hoxha, Mirjam ^b,c   Hutchinson, Amy ^a   Burdette, Laurie ^a   Burke, Laura ^a   Fang, Shenying ⁱ   Tucker, Margaret A ^a   Goldstein, Alisa M ^a   Lee, Jeffrey E ⁱ   Wei, Qingyi ⁱ   Savage, Sharon A ^a   Yang, Xiaohong R ^a   Amos, Christopher ^j   Landi, Maria Teresa ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e BUFALINI HOSPITAL   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h UNIVERSITY OF L'AQUILA   (Italy)

ⁱ UNIVERSITY OF TEXAS   (United States)

^j DARTMOUTH MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CELL ELONGATION; CELL FUNCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC STABILITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; RECQ PROTEIN LIKE 4 GENE; REGULATOR OF TELOMERE ELONGATION HELICASE 1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERASE ASSOCIATED PROTEIN 1 GENE; TELOMERE; TERF2 GENE; TUMOR GENE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DYSPLASTIC NEVUS SYNDROME; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS; PIGMENTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SKIN NEOPLASMS; SUNLIGHT; TELOMERE; YOUNG ADULT;

EID: 84871668613     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052466     Document Type: Article

References (30)

1. Blasco MA, (2005) Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6: 611-622.
2. Holly EA, Kelly JW, Shpall SN, Chiu S-H, (1987) Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17: 459-468.
3. Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, et al. (2002) A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer 94: 3192-3209.
4. Tucker MA, Goldstein AM, (2002) Melanoma etiology: where are we? Oncogene 22: 3042-3052.
5. Gilchrest BA, Eller MS, Geller AC, Yaar M, (1999) The Pathogenesis of Melanoma Induced by Ultraviolet Radiation. New England Journal of Medicine 340: 1341-1348.
6. Nan H, Du M, De Vivo I, Manson JE, Liu S, et al. (2011) Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res 71: 6758-6763.
7. Han J, Qureshi AA, Prescott J, Guo Q, Ye L, et al. (2009) A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol 129: 415-421.
8. Bataille V, Kato BS, Falchi M, Gardner J, Kimura M, et al. (2007) Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo. Cancer Epidemiol Biomarkers Prev 16: 1499-1502.
9. Nan H, Qureshi A, Prescott J, De Vivo I, Han J, (2011) Genetic variants in telomere-maintaining genes and skin cancer risk. Human Genetics 129: 247-253.
10. Lens MB, Dawes M, (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150: 179-185.
11. Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, et al. (1985) Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med 312: 91-97.
12. Bale SJ, Dracopoli NC, Tucker MA, Clark WH Jr, Fraser MC, et al. (1989) Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med 320: 1367-1372.
13. Landi MT, Baccarelli A, Calista D, Pesatori A, Fears T, et al. (2001) Combined risk factors for melanoma in a Mediterranean population. Br J Cancer 85: 1304-1310.
14. Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, et al. (2005) MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 97: 998-1007.
15. Fargnoli MC, Spica T, Sera F, Pellacani G, Chiarugi A, et al. (2006) Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 98: 144-145; author reply 145-146.
16. Ghiorzo P, Bonelli L, Pastorino L, Bruno W, Barile M, et al. (2012) MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. Experimental Dermatology: In press.
17. Landi MT, Goldstein AM, Tsang S, Munroe D, Modi W, et al. (2004) Genetic susceptibility in familial melanoma from northeastern Italy. Journal of Medical Genetics 41: 557-566.
18. Mirabello L, Richards EG, Duong LM, Yu K, Wang Z, et al. (2011) Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet 2: 19-29.
19. Liang XS, Pfeiffer RM, Wheeler W, Maeder D, Burdette L, et al. (2011) Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations. International Journal of Cancer: n/a-n/a.
20. Amos CI, Wang LE, Lee JE, Gershenwald JE, Chen WV, et al. (2011) Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet 20: 5012-5023.
21. Cawthon RM, (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30: e47.
22. Wigginton JE, Cutler DJ, Abecasis GR, (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76: 887-893.
23. Shin J-H, Blay S, McNeney B, Graham J, (2006) LDheatmap: An R Function for Graphical Display of Pairwise Linkage Disequilibria Between Single Nucleotide Polymorphisms. J Stat Soft 16: 1-9.
24. Pfeiffer RM, Gail MH, Pee D, (2009) On Combining Data From Genome-Wide Association Studies to Discover Disease-Associated SNPs. Statistical Science 24: 547-560.
25. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, et al. (2009) Pathway analysis by adaptive combination of P-values. Genet Epidemiol 33: 700-709.
26. Simon T, Kohlhase J, Wilhelm C, Kochanek M, De Carolis B, et al. (2010) Multiple malignant diseases in a patient with Rothmund-Thomson syndrome with RECQL4 mutations: Case report and literature review. Am J Med Genet A 152A: 1575-1579.
27. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
28. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, et al. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41: 905-908.
29. Varadi V, Brendle A, Brandt A, Johansson R, Enquist K, et al. (2009) Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Eur J Cancer 45: 3008-3016.
30. Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, et al. (2006) MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma. Science 313: 521-522.